Hamel Lawrence G
Chief Development Officer at TLPH
- Sold, on record
- $111k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Oct 15, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TLPHACELRX PHARMACEUTICALS INCChief Development Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale TLPHPlan not statedSep 25 2017
Sold 13,827 shares
Hamel Lawrence G, Chief Development Officer
Sold 16.8% of holdings68,504 shares leftFirst sale on recordFiling
- 2 Form 4 sale TLPHPlan not statedOct 2 +7 days
Sold 10,161 shares at $5.29 ($54k)
Hamel Lawrence G, Chief Development Officer
Sold 19.5% of holdings ($276k position)41,964 shares leftFiling
- 3 Form 4 sale TLPHPlan not statedSep 24 +357 days
Sold 6,953 shares at $4.50 ($31k)
Hamel Lawrence G, Chief Development Officer
Sold 16.6% of holdings ($189k position)35,011 shares leftFiling
- 4 Form 4 sale TLPHPlan not statedOct 15 +21 days
Sold 5,216 shares at $5.00 ($26k)
Hamel Lawrence G, Chief Development Officer
Sold 14.9% of holdings ($175k position)29,795 shares left0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2018 | TLPH | Chief Development Officer | Form 4 sale | 5,216 | $26k | 14.9% | Plan not stated | SEC |
| Sep 24, 2018 | TLPH | Chief Development Officer | Form 4 sale | 6,953 | $31k | 16.6% | Plan not stated | SEC |
| Oct 2, 2017 | TLPH | Chief Development Officer | Form 4 sale | 10,161 | $54k | 19.5% | Plan not stated | SEC |
| Sep 25, 2017 | TLPH | Chief Development Officer | Form 4 sale | 13,827 | 16.8% | Plan not stated | SEC |